Search

Psychotic experiences and their significance

Clinical perspective from the ultra high risk (UHR) paradigm, that aims to identify people at high risk of psychotic disorder

Risk perception and risk-taking behaviour during adolescence: The influence of personality and gender

This study investigated the influence of personality characteristics and gender on adolescents' perception of risk and their risk-taking behaviour.

Longer-term increased cortisol levels in young people with mental health problems

Hair segment analyses revealed longer-term increased levels of cortisol in the past 3 months in early mental health problems

Declining transition rates to psychotic disorder in "ultra-high risk" clients: Investigation of a dilution effect

Later ultra-high risk psychosis cohorts presented with different clinical intake characteristics than earlier cohorts

Neighbourhood characteristics and the rate of identification of young people at ultra-high risk for psychosis

This study aimed to determine if the rate of identification of young people at ultra-high risk for psychosis was associated with the level of social deprivation

Response to Comment on Lin et al. Risk Factors for Decline in IQ in Youth With Type 1 Diabetes Over the 12 Years From Diagnosis/Illness Onset

This editorial response addresses each of the concerns raised by Lin et al. RE: Risk Factors for Decline in IQ in Youth With Type 1 Diabetes Over the 12...

A systematic review: Identifying the prevalence rates of psychiatric disorder in Australia's Indigenous populations

A systematic review: Identifying the prevalence rates of psychiatric disorder in Australia's Indigenous populations.

Meaningful and minimally distressing: Trans adolescents’ perspectives on sensitive research interviews

Qualitative research on sensitive topics (e.g. abuse, mental health difficulties, discrimination) is needed to understand lived experiences of complex issues. However, this type of research raises concerns about potential adverse effects on participants, especially with younger participants and those from marginalized populations. In this study, we conducted a reflexive thematic analysis of 20 trans adolescents’ (14–18 years of age) experiences of participating in research about their stigma experiences.

Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatment

Sex hormones, such as oestrogen and testosterone, display significant immune modulatory properties. This is highly relevant for transgender (trans) people who undergo gender-affirming hormone (GAH) treatment. However, only a limited number of studies have evaluated the immunological impact of GAH treatments, and almost none have assessed the impact in trans young people.

Twenty-five is not a neurobiologically determined age of maturity for gender-affirming medical decision-making

Among the increasing threats to the healthcare of transgender and gender-diverse people globally, are efforts to deny gender-affirming medical care to people under age 25 typically justified by stating that the human brain is not developed until the mid-to-late 20's. Thus, this line of reasoning states young adults are not sufficiently mature to be responsible for autonomous healthcare decision-making— at least in regard to gender-affirming care.